These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31673135)

  • 1. Zebrafish earn their drug discovery stripes.
    Cully M
    Nat Rev Drug Discov; 2019 Oct; 18(11):811-813. PubMed ID: 31673135
    [No Abstract]   [Full Text] [Related]  

  • 2. Zebrafish: a complete animal model for in vivo drug discovery and development.
    Chakraborty C; Hsu CH; Wen ZH; Lin CS; Agoramoorthy G
    Curr Drug Metab; 2009 Feb; 10(2):116-24. PubMed ID: 19275547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic approaches to toxicology in the zebrafish.
    Peterson RT; Macrae CA
    Annu Rev Pharmacol Toxicol; 2012; 52():433-53. PubMed ID: 22017682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using zebrafish models of leukemia to streamline drug screening and discovery.
    Deveau AP; Bentley VL; Berman JN
    Exp Hematol; 2017 Jan; 45():1-9. PubMed ID: 27720937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zebrafish: an emerging model system for human disease and drug discovery.
    Kari G; Rodeck U; Dicker AP
    Clin Pharmacol Ther; 2007 Jul; 82(1):70-80. PubMed ID: 17495877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of zebrafish embryos for small molecule screening related to cancer.
    Terriente J; Pujades C
    Dev Dyn; 2013 Feb; 242(2):97-107. PubMed ID: 23203901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo drug discovery in the zebrafish.
    Zon LI; Peterson RT
    Nat Rev Drug Discov; 2005 Jan; 4(1):35-44. PubMed ID: 15688071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zebrafish as a model to evaluate peptide-related cancer therapies.
    Shull AY; Hu CA; Teng Y
    Amino Acids; 2017 Dec; 49(12):1907-1913. PubMed ID: 28316026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inner Workings: Zebrafish assay forges new approach to drug discovery.
    Smuga-Otto K
    Proc Natl Acad Sci U S A; 2018 May; 115(21):5306-5308. PubMed ID: 29789338
    [No Abstract]   [Full Text] [Related]  

  • 10. Orphan Drugs and Their Impact on Pharmaceutical Development.
    Attwood MM; Rask-Andersen M; Schiöth HB
    Trends Pharmacol Sci; 2018 Jun; 39(6):525-535. PubMed ID: 29779531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery.
    Ruggeri BA; Camp F; Miknyoczki S
    Biochem Pharmacol; 2014 Jan; 87(1):150-61. PubMed ID: 23817077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic applications of iminosugars: current perspectives and future opportunities.
    Horne G; Wilson FX
    Prog Med Chem; 2011; 50():135-76. PubMed ID: 21315930
    [No Abstract]   [Full Text] [Related]  

  • 13. Modeling colorectal cancer as a 3-dimensional disease in a dish: the case for drug screening using organoids, zebrafish, and fruit flies.
    Markstein M
    Drug Discov Today Technol; 2013; 10(1):e73-81. PubMed ID: 24050233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug development for rare cancers in children.
    Gore L
    Clin Adv Hematol Oncol; 2017 Jun; 15(6):441-443. PubMed ID: 28749903
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of zebrafish apoptosis assays for preclinical drug discovery.
    McGrath P; Seng WL
    Expert Opin Drug Discov; 2013 Oct; 8(10):1191-202. PubMed ID: 23964640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zebrafish assays for drug toxicity screening.
    Rubinstein AL
    Expert Opin Drug Metab Toxicol; 2006 Apr; 2(2):231-40. PubMed ID: 16866609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-content drug screening for rare diseases.
    Bellomo F; Medina DL; De Leo E; Panarella A; Emma F
    J Inherit Metab Dis; 2017 Jul; 40(4):601-607. PubMed ID: 28593466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials.
    Patton EE; Zon LI; Langenau DM
    Nat Rev Drug Discov; 2021 Aug; 20(8):611-628. PubMed ID: 34117457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical screening in zebrafish for novel biological and therapeutic discovery.
    Tan JL; Zon LI
    Methods Cell Biol; 2011; 105():493-516. PubMed ID: 21951544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Zebrafish as a model organism for biomedical studies].
    Beliaeva NF; Kashirtseva VN; Medvedeva NV; Khudoklinova IuIu; Ipatova OM; Archakov AI
    Biomed Khim; 2010; 56(1):120-31. PubMed ID: 21328916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.